http___www.takeda.hr_o-nama_takeda-u-svijetu__1.xml
1.1 2.1 2.2 2.3 3.1 3.2 3.3 4.1 4.2 5.1 6.1 7.1 7.2 7.3 8.1 9.1 10.1 12.1 13.1 14.1 16.1
Osaka, Japan, June 24, 2015 --- Takeda Pharmaceutical Company Limited (“Takeda”) today announced that François-Xavier Roger has resigned effective June 26, 2015 to become chief financial officer of Nestlé S.A. Takeda president and CEO Christophe Weber commented, "François' departure does not signal a change in our strategy, which we are just starting to execute. François has played a great role to support the transformation of Takeda into a global leader, and I enjoyed working with him. Of course, his stay at Takeda has been too short and we are disappointed by his decision." Mr. Roger joined Takeda September 2, 2013 as its first global CFO with the mission to integrate Takeda's global finance functions. He created worldwide functions for financial controlling, treasury, tax, information technology, procurement, and insurance/risk management. Mr. Roger led the fast execution of Project Summit, an initiative to optimize efficiency as the next phase of Takeda’s global transformation. Mr. Roger said, "We have achieved a lot as a global management team, and I have really enjoyed my time with Takeda and in Japan. Thanks to its rich R&D pipeline, bedrock values of Takeda-ism, talented management team, and strong balance sheet, it is my strong belief that Takeda has a bright future." The succession, starting with an interim CFO, will be announced shortly. About Takeda Pharmaceutical Company Limited Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available at www.takeda.com. Contact: Jeff Cross Takeda Pharmaceutical Company Limited E-mail: Jeffrey.cross@takeda.com Tsuyoshi Tada Takeda Pharmaceutical Company Limited E-mail: tsuyoshi.tada@takeda.com
1.1 2.1 2.2 2.3 2.4 3.1 4.1 5.1 6.1 7.1 8.1 9.1
Zgrada Takeda Midosuji, sjedište Takeda Pharmaceutical Company, gradski dio Chuo-ku, Osaka, Japan Takedina misija je predvođenjem inovacija u medicini poboljšati zdravlje ljudi diljem svijeta. Takeda je najveća farmaceutska kompanija u Japanu, a posluje i u više od 70 zemalja svijeta. Osobito je snažno prisutna u Aziji, Sjevernoj Americi, Europi i na brzorastućim tržištima, uključujući Latinsku Ameriku, Rusiju i druge države ZND-a te Kinu. Takedini lijekovi prisutni su na tržištima više od 100 zemalja. Po prodaji lijekova na recept, Takeda zauzima 12. mjesto u svijetu, 14. mjesto u zemljama BRIC-a (Brazil, Rusija, Indija i Kina) te 18. mjesto u Europi. Takeda je u okviru svoje djelatnosti prisutna na područjima metaboličkih bolesti, gastroenterologije, onkologije, kardiovaskularnih bolesti, bolesti središnjeg živčanog sustava, upalnih i imunoloških bolesti te liječenja boli. Usmjerena je na plasiranje širokog portfelja proizvoda, poboljšanje prodaje novih proizvoda te neprestano usavršavanje konkurentnih proizvoda u kasnim fazama istraživanja i razvoja. Najnoviji godišnji izvještaj tvrtke Takeda Pharmaceuticals dostupan je ovdje Više podataka o tvrtki Takeda možete pronaći na mrežnim stranicama www.takeda.com. Reference: [1] Godišnji izvještaj tvrtke Takeda Pharmaceutical za 2015. godinu